Atlas Trials

MK0524A Phase IIb Study (0524A-011)(COMPLETED)

Clinical trial NCT00536237 · COMPLETED

Trial details

NCT number
NCT00536237
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Flushing
Start date
2004-08-01
Primary completion
2005-02-01
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.